BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed PMVP catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:29e54c126b9cc54d6d13@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261215
DTEND;VALUE=DATE:20261216
SUMMARY:PMVP P1/P2 readout (est.): The Evaluation of PC14586 in Patients Wi
 th Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
DESCRIPTION:The Evaluation of PC14586 in Patients With Advanced Solid Tumor
 s Harboring a TP53 Y220C Mutation (PYNNACLE)\nNCT04585750 | PHASE1/PHASE2 
 | RECRUITING | sponsor: PMV Pharmaceuticals\, Inc\nPrimary completion date
  (ESTIMATED)\; top-line results usually follow later.\nTicker PMVP (confid
 ence 0.9)\nSource: https://clinicaltrials.gov/study/NCT04585750\nSchedulin
 g/reference data from public records\; dates can move. Not investment\, le
 gal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT04585750
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
